CardioCreate is pioneering a bold, new approach to heart disease.  Instead of treating the symptoms of heart attack and heart failure, our genetically-engineered stem cells replace damaged heart tissue with healthy, functional heart tissue.  Heart disease is the greatest single component of healthcare costs today, and this regenerative approach could dramatically reduce those expenditures.  Our mission is to advance this promising technology through preclinical development and clinical trials so that it can improve the lives of millions of patients.